Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
WorkcompWire
In the News
Enlyte Releases 2025 Drug Trends Report, Part 1: Opioids Down, Migraine Meds Up
Workers' Comp
Article
Ask The Pharmacist: Bird Flu and Its Growing Impact on Public Health
How serious is the threat of bird flu in North America? Bird flu, or avian influenza, is an emerging public health and industry conce
Business Insurance
In the News
Migraine meds on rise in comp despite overall drop in scripts
Business Hangout
In the News
Drug Use Insights: Migraines Rise While Opioids Decline
Claims Journal
In the News
Enlyte: Migraine Medications Continue Rising in Workers’ Comp
Workers' Comp
News Release
Enlyte Drug Trend Report: Migraine Med Use Soars in Comp Despite Overall Drop in Scripts
Annual PBM report shows increases in overall migraine meds use by nearly 9%, while opioids drop by almost 8%SAN DIEGO – April 30,